R&D Pharmaceutical Companies Mobilize To Help Victims Of Natural Disasters In Burma And China

Main Category: Aid / Disasters
Article Date: 22 May 2008 - 4:00 PDT

email to a friend   printer friendly   opinions  

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) confirms that, as in previous major natural disasters, the R&D-based pharmaceutical industry has moved quickly to provide substantial assistance for the victims of the recent cyclone in Burma and earthquake in southern China.

IFPMA Director General Dr. Harvey Bale said: "From the information supplied by our member companies and associations, emergency funding and medicines totaling USD 17.3 million have already been delivered by them or are on their way to help victims of these two catastrophes. Companies' current actions are maintaining a long tradition of prompt pharmaceutical industry support in the event of natural disasters."

Companies which have reported making donations of cash and/or medicines include: Abbott, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Johnson & Johnson, Lilly, Merck & Co., Inc., Merck KGaA, Novartis, Novo Nordisk, Pfizer, Roche, sanofi-aventis, Schering-Plough and Wyeth.

Companies work with expert partners to confirm the assistance that is actually needed and to ensure its effective application. Partner organizations that companies have reported they are working with to address these two disasters include: Americares, CARE, China Charity Federation, the Chinese Culture Network, the Chinese Ministry of Health, Direct Relief International, Heart-to-Heart International, the Japanese Federation of Economic Organizations, the Mercy Corps, the Red Cross, Project HOPE, Save the Children, Sinopharm, UNICEF and World Vision. The IFPMA member association in China, RDPAC, has helped to coordinate assistance provided by local subsidiaries of multinational pharmaceutical companies operating in China.

About the IFPMA

The International Federation of Pharmaceutical Manufacturers & Associations is a non-profit, non-governmental organisation representing national industry associations and companies from both developed and developing countries. Member companies of the IFPMA are research-based pharmaceutical, biotech and vaccine companies.

http://www.ifpma.org

• Additional
• References
• Citations